Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2023 Earnings Call Transcript

Page 9 of 9

And from our perspective, that’s essential to driving the flywheel for long-term growth. So that was really the reason for the comment. The last question of balancing demand and thinking about making sure we have a great Onso launch, that’s something that I think about every single day. I think it’s really important right now as Onso is showing a lot of promise and we do think there’s a lot of good opportunities. And the way we’re managing that is that we have specialist folks that are focusing principally on Onso. We still have one unified commercial organization, but we are definitely ramping up the intensity of focus on Onso. We don’t think that is impacting our Revio focus. And in particular, if you look out over the last six months, we’ve really pushed the Revio story hard so that we could drive and create a big funnel, and now we can execute on it, and now we’re in a position to continue executing on that funnel.

And we’re building the Onso funnel. We still need to continue to demonstrate the power of Onso and the data, and so you’ll see us continue to publish a lot more data and that will help drive the commercialization. But you’re right, it is a balancing act and it’s going to require good execution for us to stay focused. The good news is that our team has a lot of experience with multiple platform selling and it really — and thinking about how you sell solutions rather than just products. And I think that will serve us well. But it’s something we have to stay focused on. So I appreciate you highlighting it, Ross.

Operator: And ladies and gentlemen, this concludes our question-and-answer session. I would like to turn the conference back over to Todd Friedman for any closing remarks.

Todd Friedman: Thanks, Chad, and thank you all for joining our call. That concludes it for today. We look forward to catching up with many of you at our conferences and investor events this quarter and updating you on our Q2 progress this summer. Thank you and talk soon.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Pacific Biosciences Of California Inc. (NASDAQ:PACB)

Page 9 of 9